Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono district, Uganda

Research output: Contribution to journalJournal articlepeer-review

Standard

Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono district, Uganda. / Hansen, Kristian Schultz; Pedrazzoli, Debora; Mbonye, Anthony; Clarke, Sian; Cundill, Bonnie; Magnussen, Pascal; Yeung, Shunmay.

In: Health Policy and Planning, Vol. 28, No. 2, 2013, p. 185–196.

Research output: Contribution to journalJournal articlepeer-review

Harvard

Hansen, KS, Pedrazzoli, D, Mbonye, A, Clarke, S, Cundill, B, Magnussen, P & Yeung, S 2013, 'Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono district, Uganda', Health Policy and Planning, vol. 28, no. 2, pp. 185–196. https://doi.org/10.1093/heapol/czs048

APA

Hansen, K. S., Pedrazzoli, D., Mbonye, A., Clarke, S., Cundill, B., Magnussen, P., & Yeung, S. (2013). Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono district, Uganda. Health Policy and Planning, 28(2), 185–196. https://doi.org/10.1093/heapol/czs048

Vancouver

Hansen KS, Pedrazzoli D, Mbonye A, Clarke S, Cundill B, Magnussen P et al. Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono district, Uganda. Health Policy and Planning. 2013;28(2):185–196. https://doi.org/10.1093/heapol/czs048

Author

Hansen, Kristian Schultz ; Pedrazzoli, Debora ; Mbonye, Anthony ; Clarke, Sian ; Cundill, Bonnie ; Magnussen, Pascal ; Yeung, Shunmay. / Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono district, Uganda. In: Health Policy and Planning. 2013 ; Vol. 28, No. 2. pp. 185–196.

Bibtex

@article{42fa466ef7ce45bc9a4f631c1bb96043,
title = "Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono district, Uganda",
abstract = "In Uganda, as in many parts of Africa, the majority of the population seek treatment for malaria in drug shops as their first point of care; however, parasitological diagnosis is not usually offered in these outlets. Rapid diagnostic tests (RDTs) for malaria have attracted interest in recent years as a tool to improve malaria diagnosis, since they have proved accurate and easy to perform with minimal training. Although RDTs could feasibly be performed by drug shop vendors, it is not known how much customers would be willing to pay for an RDT if offered in these settings. We conducted a contingent valuation survey among drug shop customers in Mukono District, Uganda. Exit interviews were undertaken with customers aged 15 years and above after leaving a drug shop having purchased an antimalarial and/or paracetamol. The bidding game technique was used to elicit the willingness-to-pay (WTP) for an RDT and a course of artemisinin-based combination therapy (ACT) with and without RDT confirmation. Factors associated with WTP were investigated using linear regression. The geometric mean WTP for an RDT was US$0.53, US$1.82 for a course of ACT and US$2.05 for a course of ACT after a positive RDT. Factors strongly associated with a higher WTP for these commodities included having a higher socio-economic status, no fever/malaria in the household in the past 2 weeks and if a malaria diagnosis had been obtained from a qualified health worker prior to visiting the drug shop. The findings further suggest that the WTP for an RDT and a course of ACT among drug shop customers is considerably lower than prevailing and estimated end-user prices for these commodities. Increasing the uptake of ACTs in drug shops and restricting the sale of ACTs to parasitologically confirmed malaria will therefore require additional measures.",
keywords = "Former LIFE faculty, Willingness-to-pay, contingent valuation, Drug shop, Malaria, Rapid diagnostic test, Artenisinin-based combination therapy, Uganda",
author = "Hansen, {Kristian Schultz} and Debora Pedrazzoli and Anthony Mbonye and Sian Clarke and Bonnie Cundill and Pascal Magnussen and Shunmay Yeung",
year = "2013",
doi = "10.1093/heapol/czs048",
language = "English",
volume = "28",
pages = "185–196",
journal = "Health Policy and Planning",
issn = "0268-1080",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono district, Uganda

AU - Hansen, Kristian Schultz

AU - Pedrazzoli, Debora

AU - Mbonye, Anthony

AU - Clarke, Sian

AU - Cundill, Bonnie

AU - Magnussen, Pascal

AU - Yeung, Shunmay

PY - 2013

Y1 - 2013

N2 - In Uganda, as in many parts of Africa, the majority of the population seek treatment for malaria in drug shops as their first point of care; however, parasitological diagnosis is not usually offered in these outlets. Rapid diagnostic tests (RDTs) for malaria have attracted interest in recent years as a tool to improve malaria diagnosis, since they have proved accurate and easy to perform with minimal training. Although RDTs could feasibly be performed by drug shop vendors, it is not known how much customers would be willing to pay for an RDT if offered in these settings. We conducted a contingent valuation survey among drug shop customers in Mukono District, Uganda. Exit interviews were undertaken with customers aged 15 years and above after leaving a drug shop having purchased an antimalarial and/or paracetamol. The bidding game technique was used to elicit the willingness-to-pay (WTP) for an RDT and a course of artemisinin-based combination therapy (ACT) with and without RDT confirmation. Factors associated with WTP were investigated using linear regression. The geometric mean WTP for an RDT was US$0.53, US$1.82 for a course of ACT and US$2.05 for a course of ACT after a positive RDT. Factors strongly associated with a higher WTP for these commodities included having a higher socio-economic status, no fever/malaria in the household in the past 2 weeks and if a malaria diagnosis had been obtained from a qualified health worker prior to visiting the drug shop. The findings further suggest that the WTP for an RDT and a course of ACT among drug shop customers is considerably lower than prevailing and estimated end-user prices for these commodities. Increasing the uptake of ACTs in drug shops and restricting the sale of ACTs to parasitologically confirmed malaria will therefore require additional measures.

AB - In Uganda, as in many parts of Africa, the majority of the population seek treatment for malaria in drug shops as their first point of care; however, parasitological diagnosis is not usually offered in these outlets. Rapid diagnostic tests (RDTs) for malaria have attracted interest in recent years as a tool to improve malaria diagnosis, since they have proved accurate and easy to perform with minimal training. Although RDTs could feasibly be performed by drug shop vendors, it is not known how much customers would be willing to pay for an RDT if offered in these settings. We conducted a contingent valuation survey among drug shop customers in Mukono District, Uganda. Exit interviews were undertaken with customers aged 15 years and above after leaving a drug shop having purchased an antimalarial and/or paracetamol. The bidding game technique was used to elicit the willingness-to-pay (WTP) for an RDT and a course of artemisinin-based combination therapy (ACT) with and without RDT confirmation. Factors associated with WTP were investigated using linear regression. The geometric mean WTP for an RDT was US$0.53, US$1.82 for a course of ACT and US$2.05 for a course of ACT after a positive RDT. Factors strongly associated with a higher WTP for these commodities included having a higher socio-economic status, no fever/malaria in the household in the past 2 weeks and if a malaria diagnosis had been obtained from a qualified health worker prior to visiting the drug shop. The findings further suggest that the WTP for an RDT and a course of ACT among drug shop customers is considerably lower than prevailing and estimated end-user prices for these commodities. Increasing the uptake of ACTs in drug shops and restricting the sale of ACTs to parasitologically confirmed malaria will therefore require additional measures.

KW - Former LIFE faculty

KW - Willingness-to-pay

KW - contingent valuation

KW - Drug shop

KW - Malaria

KW - Rapid diagnostic test

KW - Artenisinin-based combination therapy

KW - Uganda

U2 - 10.1093/heapol/czs048

DO - 10.1093/heapol/czs048

M3 - Journal article

C2 - 22589226

VL - 28

SP - 185

EP - 196

JO - Health Policy and Planning

JF - Health Policy and Planning

SN - 0268-1080

IS - 2

ER -

ID: 40621843